Endocarditis after transfemoral aortic valve implantation in a patient with Osler-Weber-Rendu syndrome
Key result
Surgical aortic valve replacement successfully treats post-TAVI endocarditis in Osler-Weber-Rendu syndrome.
- n=1
Why the study?
Few cases of postoperative infection by TAVI device have been reported, and treatment strategies in patients with OWR syndrome are complex.
Comparison
TAVI procedure followed by surgical aortic valve replacement
Design
Case report
Authors
Discussion
Loading...
Member takes
Implication
Endocarditis can occur late after TAVI in Osler-Weber-Rendu syndrome; leaves open whether syndrome-specific prophylaxis or surveillance is warranted.
Study Design
Type
Case Report (n=1)
Structured PICO
P
Population
1 male patient with Osler-Weber-Rendu syndrome and severe aortic stenosis who developed endocarditis one year after TAVI.
I
Intervention
Transfemoral aortic valve implantation (TAVI) followed by surgical aortic valve replacement
O
Outcome
Development of endocarditis on the TAVI device and outcome of subsequent surgical replacement
Highlights the risk of TAVI device endocarditis and demonstrates the feasibility of subsequent surgical aortic valve replacement in complex patients with bleeding risks such as Osler-Weber-Rendu syndrome.
Cite This Study
Castiglioni et al. (2012) conducted a case report in Severe aortic stenosis and Osler-Weber-Rendu syndrome (n=1). Transcatheter aortic valve implantation (TAVI) was evaluated on Endocarditis on the TAVI device. A patient with Osler-Weber-Rendu syndrome developed endocarditis one year after transcatheter aortic valve implantation, which was successfully treated with surgical aortic valve replacement.